Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome

Rev Endocr Metab Disord. 2021 Mar;22(1):81-89. doi: 10.1007/s11154-020-09591-4. Epub 2020 Sep 16.

Abstract

Since 1994, we have been studying an extended kindred with 105 subjects (over 8 generations) residing in Itabaianinha County, in the Brazilian state of Sergipe, who have severe isolated GH deficiency (IGHD) due to a homozygous inactivating mutation (c.57 + 1G > A) in the GH releasing hormone (GHRH) receptor (GHRHR) gene. Most of these individuals have never received GH replacement therapy. They have low GH, and very low and often undetectable levels of serum IGF-I. Their principal physical findings are proportionate short stature, doll facies, high-pitched-voice, central obesity, wrinkled skin, and youthful hair with delayed pigmentation, and virtual absence of graying. The newborns from this cohort are of normal size, indicating that GH is not needed for intra-uterine growth. However, these IGHD individuals exhibit a myriad of phenotypic changes throughout the body, with a greater number of beneficial than harmful consequences. This GHRH signal disruption syndrome has been a valuable model to study the GH roles in body size and function. This reviews summarized the findings we have reported on this cohort.

Keywords: GH; GHRH; GHRH receptor; IGF-I; IGF-II.

Publication types

  • Review

MeSH terms

  • Adult
  • Brazil
  • Child
  • Dwarfism, Pituitary*
  • Humans
  • Infant, Newborn
  • Mutation
  • Receptors, Neuropeptide / genetics
  • Receptors, Pituitary Hormone-Regulating Hormone* / genetics

Substances

  • Receptors, Neuropeptide
  • Receptors, Pituitary Hormone-Regulating Hormone
  • somatotropin releasing hormone receptor